Ultimovacs ASA: Invitation to first quarter 2024 results webcast presentation

Oslo, April 30, 2024: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing immunotherapeutic cancer vaccines, invites to a webcast presentation of its first quarter 2024 results on Tuesday, May 7, 2024.

The presentation can be followed as a live webcast accessed through a link on www.ultimovacs.com at 14:00 CET on Tuesday, May 7, 2024, and is scheduled to conclude at 14:55 CET. The webcast presentation will be available on the Ultimovacs website, and it will be possible to post questions during the presentation through the webcast.

The report and presentation will be available on the company website from 07:00 CET the same day.

For further information, please see www.ultimovacs.com or contact:

Carlos de Sousa, CEO
Email: [email protected]
Phone: +47 908 92507

Hans Vassgård Eid, CFO
Email: [email protected]
Phone: +47 482 48632

Anne Worsøe, Head of Investor Relations
Email: [email protected]
Phone: +47 906 86815